Evolution of the Average Target: Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

f6323f2305bd.i8CgmeApKnbHKUYK7-m9wf5Fi-KiT5T4hG6e6J5EH-8.5IPHrLNcZluKSAJ6qKfXipV0yo74AOen8iPYuN83W67NkMrjlRxdT5ZFEw~2b9a4e3222f90e6a0d5b8149906b2a2e
08-01 Stride Shares Fall After William Blair Downgrade MT
07-31 William Blair Downgrades Stride to Market Perform From Outperform MT
29/10/25 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
29/10/25 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
06/10/25 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
29/08/25 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
06/08/25 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
06/08/25 Stride Q4 revenue, adjusted EPS beat estimates RE
30/04/25 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
30/04/25 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
21/04/25 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
21/04/25 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
29/01/25 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
23/10/24 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
21/08/24 Stride Shares Fall After Citigroup Downgrade MT
20/08/24 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
08/08/24 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
08/08/24 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
31/07/24 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24/04/24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
26/01/24 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
25/01/24 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
25/01/24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
17/11/23 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
16/11/23 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+24.89%
+24.57%
+31.79%
+10.61%
+19.4%
+29.92%
+22.96%
- - +33.37%
+32.62%
+18.02%
Average +24.82%
Weighted average by Cap. +24.37%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
87.28USD
Average target price
109.00USD
Spread / Average Target
+24.89%
High Price Target
125.00USD
Spread / Highest target
+43.22%
Low Price Target
93.00USD
Spread / Lowest Target
+6.55%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. LRN Stock
  4. Consensus Stride, Inc.